Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 30, 2019
Outpatient pulmonary rehabilitation for severe asthma with fixed airway obstruction: Comparison with COPDAgnès Bellocq, Wanda Gaspard, Camille Couffignal, et al.Journal of Geriatric Cardiology : JGC|September 1, 2020
Quality of life, physical performance and nutritional status in older patients hospitalized in a cardiology departmentMatthieu Lilamand, Mariannick Saintout, Marie Vigan, et al.Eclinicalmedicine|November 11, 2020
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept studyDjillali Annane, Nicholas Heming, Lamiae Grimaldi-Bensouda, et al.Obesity Surgery|March 29, 2023
Nutritional Status of Vegetarian Patients Before and After Bariatric Surgery: a Monocentric Retrospective Observational Case-Control StudyAurélie Phan, Mirella Hage, Ramona Zaharia, et al.The AAPS Journal|December 11, 2012
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patientsDinko Rekić, Daniel Röshammar, Martin Bergstrand, et al.The American Journal of Sports Medicine|October 25, 2019
Outcomes After Latarjet Procedure: Patients With First-Time Versus Recurrent DislocationsAlexandre Hardy, Vincent Sabatier, Pierre Laboudie, et al.The American Journal of Sports Medicine|December 27, 2019
Outcomes of the Latarjet Procedure for the Treatment of Chronic Anterior Shoulder Instability: Patients With Prior Arthroscopic Bankart Repair Versus Primary CasesJean-David Werthel, Vincent Sabatier, Bradley Schoch, et al.Journal of Clinical Microbiology|July 5, 2012
Phylogenetic distribution of CTX-M- and non-extended-spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymesSylvain Brisse, Laure Diancourt, Cédric Laouénan, et al.Antimicrobial Agents and Chemotherapy|March 6, 2013
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trialJean-Jacques Parienti, Aurélie Barrail-Tran, Xavier Duval, et al.The Journal of Antimicrobial Chemotherapy|November 27, 2018
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)Véronique Joly, Charles Burdet, Roland Landman, et al.Pageof 5